Mir Zulqarnain
Hospitalist · Kansas City, MONPI 1780145458
Payments from drug & device makers
What this record shows
This record is dominated by grants: $160,000 of the $160,984 with a category attached, or 99.4%. Pfizer accounts for 99.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $160,221, more than ten times the $178 reported in 2022. Among hospitalist clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 11 payments — averaging $14,635 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$160K
- AbbVie$361
- Gilead$238
- Intercept Pharmaceuticals, Inc.$125
- Phathom Pharmaceuticals, Inc.$104
- Regeneron Healthcare Solutions, Inc.$101
- plus $54 from 1 others
What the payments were for
- Grants$160,00099%
- Food & beverage$9841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 2 | $160,000 |
| AbbVie | 3 | $361 |
| Gilead | 2 | $238 |
| Intercept Pharmaceuticals, Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $104 |
| Regeneron Healthcare Solutions, Inc. | 1 | $101 |
| Boston Scientific | 1 | $54 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$160,984 in reported general payments places this provider in the 95th percentile of 712 hospitalist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 27 | $386 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Kansas City
- Todd ShafferKansas City$2K
- Alexander GabrovskyKansas City$899
- Patricia CoxKansas City$886
- Tomica BlockerKansas City$794
- Gian MusarraSaint Louis$25K
- Ghassan DaherSaint Louis$23K
- Marsha SchulteSaint Louis$23K
- Ijeoma NwelueSaint Louis$12K
- Karan MohanSt. Joseph$6K
- Aniesh BobbaColumbia$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.